Healthcare - Biotechnology - NASDAQ - US
$ 1.32
-6.38 %
$ 1.86 M
Market Cap
-0.13
P/E
INCOME STATEMENT
0
REVENUE
-17.9 M
OPERATING INCOME
-11.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Allarity Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 37 K |
| Gross Profit | -37 K |
| Operating Expenses | 17.9 M |
| Operating Income | -17.9 M |
| Other Expenses | -6.03 M |
| Net Income | -11.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0.1 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 37 K | 0.1 | 0.1 | 86 K | 0 |
| Gross Profit | 37 K | (0.1) | (0.1) | 86 K | 0.1 |
| OPERATING INCOME | |||||
| Operating Expenses | 17.9 | 16.9 | 26.6 | 9.2 | 10.2 |
| Selling, General and Administrative Expenses | 10.0 | 10.0 | 12.4 | 4.1 | 3.9 |
| Research and Development Expenses | 7.9 | 6.9 | 14.2 | 5.1 | 6.4 |
| Operating Income | (17.9) | (34.5) | (26.6) | (9.2) | (17.6) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0.5 | 0.2 | 0.5 | 0.2 | 3.3 |
| Total Other Income | 5.3 | (0.7) | 41 K | 1.9 | (8.9) |
| Pre-Tax Income | (12.6) | (17.6) | (26.5) | (7.2) | (19.0) |
| NET INCOME | |||||
| Tax Provision | (0.7) | (1.5) | 0.1 | (2.2) | (4.6) |
| Net Income | (11.9) | (16.1) | (26.6) | (5.1) | (14.4) |
| EPS | 205 | 47.2 K | (0.1) | 43.5 K | 6.36 K |